| pubmed-article:2166528 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2166528 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:2166528 | lifeskim:mentions | umls-concept:C0205369 | lld:lifeskim |
| pubmed-article:2166528 | lifeskim:mentions | umls-concept:C1149380 | lld:lifeskim |
| pubmed-article:2166528 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:2166528 | lifeskim:mentions | umls-concept:C1268874 | lld:lifeskim |
| pubmed-article:2166528 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2166528 | pubmed:dateCreated | 1990-9-17 | lld:pubmed |
| pubmed-article:2166528 | pubmed:abstractText | Several N-(2-methyl or 1,2-dimethylindol-3-ylglyoxylyl)amino acid derivatives were synthesized and tested for their affinity for the benzodiazepine receptor in bovine cortical membranes. The 2-methyl derivatives showed a lower affinity than the unmethylated analogues, and the 1,2-dimethyl derivatives practically lacked any affinity for the benzodiazepine receptor. The importance of the indole N-H group is therefore evidenced for an optimal interaction of these ligands with receptor site. | lld:pubmed |
| pubmed-article:2166528 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2166528 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2166528 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2166528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2166528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2166528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2166528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2166528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2166528 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2166528 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:2166528 | pubmed:issn | 0014-827X | lld:pubmed |
| pubmed-article:2166528 | pubmed:author | pubmed-author:LucacchiniAA | lld:pubmed |
| pubmed-article:2166528 | pubmed:author | pubmed-author:MartinsUU | lld:pubmed |
| pubmed-article:2166528 | pubmed:author | pubmed-author:SalvadoriCC | lld:pubmed |
| pubmed-article:2166528 | pubmed:author | pubmed-author:PrimofioreGG | lld:pubmed |
| pubmed-article:2166528 | pubmed:author | pubmed-author:GiannacciniGG | lld:pubmed |
| pubmed-article:2166528 | pubmed:author | pubmed-author:Da SettimoFF | lld:pubmed |
| pubmed-article:2166528 | pubmed:author | pubmed-author:MariniA MAM | lld:pubmed |
| pubmed-article:2166528 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2166528 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:2166528 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2166528 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2166528 | pubmed:pagination | 341-51 | lld:pubmed |
| pubmed-article:2166528 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:meshHeading | pubmed-meshheading:2166528-... | lld:pubmed |
| pubmed-article:2166528 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2166528 | pubmed:articleTitle | Specific inhibition of benzodiazepine receptor binding by some N-(2-methyl or 1,2-dimethylindol-3-ylglyoxylyl)amino acid derivatives. | lld:pubmed |
| pubmed-article:2166528 | pubmed:affiliation | Istituto di Chimica Farmaceutica dell'Università di Pisa, Italy. | lld:pubmed |
| pubmed-article:2166528 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2166528 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:2166528 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
